Chemical Structure (Kadcyla 01)
Kadcyla Injection, Powder, Lyophilized, For Solution
Product Images NDC 50242-088
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Kadcyla (NDC 50242-088). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Kadcyla 02)
Figure 2 (Kadcyla 03)
This is a survival analysis of patients (n=496) treated with ado-trastuzumab emtansine compared to lapatinib plus capecitabine. The analysis compares the duration of survival in months and shows the number of patients at risk along the way. The hazard ratio and p-value are estimated using a stratified Cox model and log-rank test, respectively. The text seems to be presenting a graph or a chart; however, only the text information extractable from the graphic is given, and the graph's image is not available.*
Figure 3 (Kadcyla 04)
Principal Display Panel (100 mg Vial Carton)
Kadcyla is a medication that requires intravenous infusion. This medication comes in a single-dose vial with a strength of 100 mg. Prior to administration, the medication must be reconstituted and diluted. Any unused portion of the product in the single-dose vial should be discarded. Kadcyla must be kept refrigerated. The manufacturer of this medication is Genentech and the product is identified by the National Drug Code (NDC) number 50242-088-01.*
Principal Display Panel (160 mg Vial Carton)
Kadcyla® (ado-trastuzumab emtansine) is a medication that is administered through intravenous infusion only. It comes in a single-dose vial containing 160 mg per vial. The medication should be reconstituted and diluted before administration. Any unused portion should be discarded. The medication should be refrigerated and the given NDC code is 50242-087-01.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
